IQVIA™ Real-World Insights Bibliography

Uncovering the burden of influenza in children in Portugal, 2008?2018
Author(s): Alberto Caldas Afonso 1 2 3 4, Catarina Gouveia 5 6, Gustavo Januário 7 8, Mafalda Carmo 9, Hugo Lopes 10 11 12, Hélène Bricout 13, Catarina Gomes 14, Filipe Froes 15
Affiliations(s): 1Unidade de Nefrologia Pediátrica, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto, Porto, Portugal. caldasafonso.cmin@chporto.min-saude.pt. 2Centro Hospitalar Universitário Santo António, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal. caldasafonso.cmin@chporto.min-saude.pt. 3EPIUnit - Instituto de Saúde Pública, Porto, Portugal. caldasafonso.cmin@chporto.min-saude.pt. 4Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional, Porto, Portugal. caldasafonso.cmin@chporto.min-saude.pt. 5Hospital D. Estefânia, Centro Hospitalar Lisboa Central, Lisboa, Portugal. 6Faculdade de Ciências Médicas, Nova Medical School, Lisbon, Portugal. 7Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. 8Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal. 9IQVIA, Barcelona, Spain. 10IQVIA, Lisbon, Portugal. 11NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal. 12Comprehensive Health Research Center - Universidade NOVA de Lisboa, Lisbon, Portugal. 13Sanofi, Lyon, France. 14Sanofi, Lisbon, Portugal. 15Hospital Pulido Valente, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Publication(s):  Caldas Afonso A, Gouveia C, Januário G, Carmo M, Lopes H, Bricout H, Gomes C, Froes F. Uncovering the burden of Influenza in children in Portugal, 2008-2018. BMC Infect Dis. 2024 Jan 18;24(1):100. doi: 10.1186/s12879-023-08685-z. PMID: 38238649; PMCID: PMC10797867.
Document Type(s): Article,
Countries: Portugal,
Click here for the abstract
C:
Y:
Infectious disease, Respiratory disease,
2024
  L:
A:
English
Burden of illness,
  Add to report
 
 
Addressing influenza's underestimated burden - Iberian experts call to action
Author(s): Ángel Gil-de-Miguel 1 2, Javier Díez-Domingo 3, Federico Martinón-Torres 4 5 6, Esther Redondo Margüello 7, Raúl Ortiz de Lejarazu Leonardo 8, Tomàs Pumarola 9, Jaime Correia de Sousa 10, Carlos Rabaçal 11, João Raposo 12, Carlos Robalo Cordeiro 13, Filipe Froes 14
Affiliations(s): 1Public Health and Medical Specialties Department, Health Sciences Faculty, Rey Juan Carlos University, Madrid, Spain. angel.gil@urjc.es. 2Universidad Rey Juan Carlos, Avda. de Atenas, s/n, 28922, Alcorcón, Madrid, Spain. angel.gil@urjc.es. 3Vaccine Research Department, University of Valencia, Valencia, Spain. 4Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela, Galicia, Spain. 5Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain. 6CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain. 7International Health Center Madrid Health, City Council of Madrid, Madrid, Spain. 8National Influenza Centre, Hospital Clínico Universitario, Universidad de Valladolid, Valladolid, Spain. 9Department of Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. 10Life and Health Sciences Research Institute (ICVS), School of Medicine, PT Government Associate Laboratory, University of Minho, Braga Portugal. ICVS/3B's, Braga/Guimarães, Portugal. 11Vila Franca de Xira Hospital, Lisbon, Portugal. 12APDP and Nova Medical School, Lisbon, Portugal. 13Pulmonology Department, Coimbra University Hospital, University of Coimbra, Coimbra, Portugal. 14Thorax Department, ICU, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Publication(s): 
Document Type(s): Article,
Countries: Portugal, Spain,
Click here for the abstract
C:
Y:
Infectious disease, Respiratory disease,
2023
  L:
A:
English
Burden of illness,
  Add to report
 
 
Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015-2018
Author(s): Teresa Bandeira 1, Mafalda Carmo 2, Hugo Lopes 3, Catarina Gomes 4, Margarida Martins 4, Carlos Guzman 5, Mathieu Bangert 6, Fernanda Rodrigues 7 8, Gustavo Januário 7 8, Teresa Tomé 9, Inês Azevedo 10
Affiliations(s): 1Centro Hospitalar Universitário Lisboa Norte, Faculdade de Medicina, Universidade de Lisboa, CAML, Lisbon, Portugal. 2IQVIA, Barcelona, Spain. 3IQVIA, Lisbon, Portugal. 4Sanofi, Lisbon, Portugal. 5Sanofi, Madrid, Spain. 6Sanofi, Lyon, France. 7Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. 8Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal. 9Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal. 10Faculdade de Medicina, Universidade do Porto, Centro Hospitalar Universitário S. João; EPIUnit, Instituto de Saúde Pública, Porto, Portugal.
Publication(s): 
Document Type(s): Article,
Countries: Portugal,
Click here for the abstract
C:
Y:
Infectious disease, Respiratory disease,
2023
  L:
A:
English
Burden of illness,
  Add to report
 
 
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018
Author(s): Janet Sultana 1 2, Salvatore Crisafulli 3, Mariana Almas 4, Ippazio Cosimo Antonazzo 5 6, Esme Baan 7, Claudia Bartolini 6, Maria Paola Bertuccio 3, Fedele Bonifazi 8 9, Annalisa Capuano 10 11, Antonella Didio 8 9, Vera Ehrenstein 12, Mariagrazia Felisi 8 13, Carmen Ferrajolo 10 11, Andrea Fontana 14, Remy Francisca 7, Annie Fourrier-Reglat 15, Joan Fortuny 16, Rosa Gini 6, Giulia Hyeraci 6, Christel Hoeve 7, Christos Kontogiorgis 17, Valentina Isgrò 18, Panagiotis-Nikolaos Lalagkas 17, Luca L'Abbate 18, Deborah Layton 19, Annalisa Landi 8 9, Silvia Narduzzi 19, Leonardo Roque Pereira 20, Georgios Poulentzas 17, Concetta Rafaniello 10 11, Giuseppe Roberto 6, Giulia Scondotto 3, Liberata Sportiello 10 11, Maddalena Toma 8 9, Massoud Toussi 19, Katia Verhamme 7, Elisabetta Volpe 8 9, Gianluca Trifirò 18,
Affiliations(s): Pharmacy Department, Mater Dei Hospital, Msida, Malta. 2Exeter College of Medicine and Health, Exeter, UK. 3Department of Medicine, University of Verona, Verona, Italy. 4Real World Solutions Department, IQVIA, Lisbon, Portugal. 5Research Centre on Public Health (CESP), University of Milan-Bicocca, Milan, Italy. 6Agenzia Regionale di Sanità della Toscana, Florence, Italy. 7Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, The Netherlands. 8TEDDY European Network of Excellence for Paediatric Clinical Research, Pavia, Italy. 9Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy. 10Department of Experimental Medicine, University of Campania "Vanvitelli", Naples, Italy. 11Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy. 12Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. 13CVBF Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy. 14Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. 15Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, Team of Pharmacoepidemiology, UMR 1219, Bordeaux, France. 16RTI Health Solutions, Barcelona, Spain. 17Democritus University of Thrace, Alexandroupolis, Greece. 18Department of Diagnostics and Public Health, University of Verona, Verona, Italy. 19Data Science Hub, Real World Solutions, IQVIA, London, UK. 20Department of Datascience & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands.
Publication(s):  Pharmacoepidemiol Drug Saf . 2022 Jun;31(6):689-705. doi: 10.1002/pds.5413. Epub 2022 Feb 11.
Document Type(s): Article,
Countries: Denmark, France, Italy, Netherlands, Portugal, Spain, UK,
Click here for the abstract
C:
Y:
Drug safety, Drug Utlization Study,
2022
  L:
A:
English
Database Study, Review,
  Add to report
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal
Author(s): Nuno Marques 1, Laetitia Gerlier 2, Mafalda Ramos 3, Helder Pereira 4, Sérgia Rocha 5, Ana Catarina Fonseca 6, Ana André 7, Ricardo Melo 8, Eduard Sidelnikov 9
Affiliations(s): 1Department of Cardiology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal. 2IQVIA, Zaventem, Belgium. 3IQVIA, Zaventem, Belgium. Electronic address: mafalda.ramos@iqvia.com. 4Department of Cardiology, Hospital Garcia de Orta, Almada, Portugal. 5Department of Cardiology, Hospital de Braga, Braga, Portugal. 6Department of Neurology, Hospital de Santa Maria, Universidade de Lisboa, Lisboa, Portugal. 7Department of Neurology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal. 8Amgen SA, Portugal. 9Amgen (Europe) GmbH, Rotkreuz, Switzerland.
Publication(s):  PMID: 33581948 DOI: 10.1016/j.repc.2020.05.019 IQVIA HEOR Zaventem Brussels
Revista Portuguesa de Cardiologia Volume 40, Issue 2, February 2021, Pages 109-115.
Document Type(s): Article,
Countries: Portugal,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2021
  L:
A:
English
Burden of illness, Clinical setting: Primary care, Prospective study,
  Add to report
 
 
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publication(s):  IPVC, Barcelona, Spain, 23-27 March 2020
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Portugal, Spain,
C:
Y:
Infectious disease, Oncology,
2020
  L:
A:
English
Burden of illness, Observational study, Retrospective Field Study,
  Add to report
 
 
EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES TARGETING PHYSICIANS ON PRESCRIBING PRACTICES OF THIOCOLCHICOSIDE (TCC) CONTAINING MEDICINAL PRODUCTS FOR SYSTEMIC USE
Author(s): Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka de Voogd, Massoud Toussi
Affiliations(s): Real World Evidence Solutions, IQVIA, France; Global Pharmacovigilance ? Global Safety Sciences - Risk Management, Sanofi; Epidemiology and Benefit Risk Evaluation, Sanofi; Global Clinical Sciences; Vaccines & Anti-Infectives, Mylan, The Netherlands
Publication(s):  Poster presented at: 35th International Conference an Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Pennsylvania Convention Center Philadelphia, Pennsylvania August 24-28, 2019
Document Type(s): Poster,
Countries: France, Greece, Italy, Portugal,
Click here for the abstract
C:
Y:
Health policy, Musculoskeletal disease,
2019
  L:
A:
English
Survey research,
  Add to report
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe
Author(s): Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5
Affiliations(s): 1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium
Publication(s):  Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157.
Document Type(s): Article,
Countries: Belgium, France, Poland, Portugal, Spain, Switzerland, UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2019
  L:
A:
English
Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study,
  Add to report
 
 
Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use
Author(s): Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M
Affiliations(s): IQVIA
Publication(s):  Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372
Document Type(s): Article,
Countries: France, Greece, Italy, Portugal,
Click here for the abstract
C:
Y:
Musculoskeletal disease, Rheumatology, Risk Management & REMS,
2019
  L:
A:
English
Survey research,
  Add to report
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.
Author(s): Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5
Affiliations(s): 1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France
Publication(s):  European Society of Cardiology (ESC) Congress, 2018, Munich, Germany
Document Type(s): Poster,
Countries: Belgium, France, Poland, Portugal, Spain, Switzerland, UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2018
  L:
A:
English
Burden of illness, Cost of illness,
  Add to report
 
 
 1 of 3 Next Page Last Page